Financhill
Back

Supernus Pharmaceuticals 10K Form

Sell
38

SUPN
Supernus Pharmaceuticals

Last Price:
$31.60
Seasonality Move:
11.77%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive SUPN News And Ratings

See the #1 stock for the next 7 days that we like better than SUPN

SUPN Financial Statistics

Sales & Book Value

Annual Sales: $661.8M
Cash Flow: $30.3M
Price / Cash Flow: 11.07
Annual Sales: $18.41
Price / Book: 1.75

Profitability

EPS (TTM): 1.11000
Net Income (TTM): $61.9M
Gross Margin: $583.9M
Return on Equity: 6.24%
Return on Assets: 4.64%

Supernus Pharmaceuticals Earnings Forecast

Key Supernus Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 16 years for SUPN is 88.23%.
  • The Selling, General & Administrative Expenses for SUPN have been equal to 48.59% of Gross Profit Margin.
  • The Research & Development expenses have been 16.44% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of SUPN is 11.16% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 10 years.

Supernus Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: SUPN
CUSIP: 868459
Website: supernus.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.44
Quick Ratio: 2.16

Price-to-Earnings

Trailing P/E Ratio: 24.45
Forward P/E Ratio: 12.46

SUPN Technical Analysis vs Fundamental Analysis

Sell
38
Supernus Pharmaceuticals (SUPN) is a Sell

Is Supernus Pharmaceuticals a Buy or a Sell?